Variant report
Variant | nsv397981 |
---|---|
Chromosome Location | chr8:11017912-11018421 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AF131215.4.1-2 | chr8:11018301-11019737 | ucscGeneNc_uc010lrv_1 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574787002 | chr8:11017974-11017975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542198487 | chr8:11018024-11018025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540429838 | chr8:11018025-11018026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183324165 | chr8:11018032-11018033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34189474 | chr8:11018037-11018038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368690549 | chr8:11018045-11018046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533377006 | chr8:11018048-11018049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543427067 | chr8:11018057-11018058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs372407135 | chr8:11018067-11018068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188567021 | chr8:11018078-11018079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376262865 | chr8:11018098-11018099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192769077 | chr8:11018125-11018126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375713676 | chr8:11018137-11018138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375267094 | chr8:11018142-11018143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559627984 | chr8:11018143-11018144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184842945 | chr8:11018146-11018147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146632934 | chr8:11018185-11018186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369155116 | chr8:11018190-11018191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149207183 | chr8:11018191-11018192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62488586 | chr8:11018198-11018199 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570586811 | chr8:11018212-11018213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534835091 | chr8:11018215-11018216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372935705 | chr8:11018226-11018227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374975870 | chr8:11018277-11018278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9987122 | chr8:11018282-11018283 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs536048808 | chr8:11018314-11018315 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs557342136 | chr8:11018319-11018320 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs9987131 | chr8:11018321-11018322 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs575909999 | chr8:11018337-11018338 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs536622264 | chr8:11018346-11018347 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs140721780 | chr8:11018357-11018358 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs577005188 | chr8:11018358-11018359 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs60863755 | chr8:11018407-11018408 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs7834546 | chr8:11018409-11018410 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs78855645 | chr8:11018421-11018422 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Gastric cancer | 21811585 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:10966400-11026200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:10997200-11021000 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
3 | chr8:10999400-11021000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr8:11001600-11021000 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
5 | chr8:11002800-11022000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr8:11006800-11026200 | Weak transcription | HSMM | muscle |
7 | chr8:11009200-11021000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr8:11009200-11024800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr8:11009800-11021400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr8:11012000-11021400 | Weak transcription | Gastric | stomach |
11 | chr8:11012000-11022400 | Weak transcription | H9 Cell Line | embryonic stem cell |
12 | chr8:11013200-11021000 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr8:11013400-11026400 | Weak transcription | Esophagus | oesophagus |
14 | chr8:11013600-11028800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr8:11014800-11021400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr8:11015400-11021600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr8:11015600-11021200 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
18 | chr8:11015600-11022400 | Enhancers | Primary B cells from peripheral blood | blood |
19 | chr8:11016000-11021800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr8:11016600-11021400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
21 | chr8:11016600-11032200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
22 | chr8:11017200-11021000 | Weak transcription | Pancreas | Pancrea |
23 | chr8:11017200-11021400 | Weak transcription | Spleen | Spleen |
24 | chr8:11017400-11021200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
25 | chr8:11017400-11025400 | Weak transcription | HSMMtube | muscle |
26 | chr8:11017600-11018600 | Enhancers | GM12878-XiMat | blood |
27 | chr8:11017800-11019000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |